4//SEC Filing
CymaBay Therapeutics, Inc. 4
Accession 0001042074-17-000013
CIK 0001042074operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 2:35 PM ET
Size
5.4 KB
Accession
0001042074-17-000013
Insider Transaction Report
Form 4
Weiland Robert J.
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-28+15,000→ 15,000 totalExercise: $5.50Exp: 2027-06-27→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042074
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 2:35 PM ET
- Size
- 5.4 KB